COMP <GO>
CPB vs INGR // EV/EBITDA & P/E VALUATION
The Campbell's Company (NASDAQ) VS. Ingredion Incorporated (NYSE) • 15-METRIC TALLY: CPB 6
— INGR 7
▲ EV/EBITDA & P/E VALUATION LEADER: INGR
LAST: $21.42 (+2.00%) • MKT CAP: $6.26B
valuation
7.0x
LAST: $96.97 (+1.44%) • MKT CAP: $6.03B
valuation
4.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPB VS. INGR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPB | INGR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.40% | 25.30% | +5.10 | CPB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.80% | 16.10% | -5.30 | INGR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.0x | 4.9x | +2.10 | INGR | /valuation <GO> |
| Free Cash Flow Yield | 11.26% | 8.48% | +2.78 | CPB | /fcf-yield <GO> |
| Operating Margin | 11.00% | 14.10% | -3.10 | INGR | /operating-margins <GO> |
| Net Profit Margin | 5.90% | 10.10% | -4.20 | INGR | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | -2.80% | +9.20 | CPB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.33% | 3.50% | +3.83 | CPB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.68 | 3.69 | -2.01 | INGR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.1 | 45.9 | +10.20 | CPB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.16 | -0.17 | INGR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.7x | 7.7x | +2.00 | INGR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.26B | $6.03B | $234.6M | CPB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPB REV | INGR REV | CPB GROSS % | INGR GROSS % | CPB FCF | INGR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.25B | $7.22B | 30.4% | 25.3% | $705.0M | $511.0M |
| FY 2024 | $9.64B | $7.43B | 30.8% | 24.1% | $668.0M | $1.14B |
| FY 2023 | $9.36B | $8.16B | — | — | $721.9M | $689.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPB // BETA 0.99
INGR // BETA 1.16